Due to health issues, this site is no longer maintained and will be shut down shortly. |
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:XTLB.
$1.21 0.00 (0.00%)
As of 03/24/2023 00:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.